Skip to main content
Normal View

Medicinal Products

Dáil Éireann Debate, Wednesday - 25 November 2020

Wednesday, 25 November 2020

Questions (222)

Róisín Shortall

Question:

222. Deputy Róisín Shortall asked the Minister for Health if consideration will be given to establishing a multi-stakeholder group to examine the efficacy of mandated risk minimisation methods in respect of prescription drugs, in particular sodium valproate, as has been called for by an organisation (details supplied); and if he will make a statement on the matter. [39016/20]

View answer

Written answers (Question to Health)

I met with the organisation referred to by the Deputy earlier this week to discuss a number of issues relating to sodium valproate. As an outcome of this meeting, I will be asking the HSE and other relevant agencies to form a stakeholder group to consider the effectiveness of risk minimisation measures in place for sodium valproate and, potentially, for other medicines.

Questions Nos. 223 and 224 answered with Question No. 189.
Top
Share